nodes	percent_of_prediction	percent_of_DWPC	metapath
Gliclazide—type 2 diabetes mellitus—metabolic syndrome X	0.696	1	CtDrD
Gliclazide—ALB—metabolic syndrome X	0.199	1	CbGaD
Gliclazide—ABCC8—penis—metabolic syndrome X	0.00342	0.475	CbGeAlD
Gliclazide—Reaction gastrointestinal—Metformin—metabolic syndrome X	0.00258	0.0779	CcSEcCtD
Gliclazide—Epigastric discomfort—Metformin—metabolic syndrome X	0.00164	0.0494	CcSEcCtD
Gliclazide—Toothache—Metformin—metabolic syndrome X	0.00141	0.0427	CcSEcCtD
Gliclazide—Nail disorder—Metformin—metabolic syndrome X	0.00133	0.0401	CcSEcCtD
Gliclazide—Upset stomach—Metformin—metabolic syndrome X	0.00131	0.0397	CcSEcCtD
Gliclazide—Heartburn—Metformin—metabolic syndrome X	0.00125	0.0378	CcSEcCtD
Gliclazide—Fungal infection—Metformin—metabolic syndrome X	0.00111	0.0337	CcSEcCtD
Gliclazide—Glyburide—ABCA1—metabolic syndrome X	0.0011	0.536	CrCbGaD
Gliclazide—Blood disorder—Metformin—metabolic syndrome X	0.00103	0.0311	CcSEcCtD
Gliclazide—Glipizide—PPARG—metabolic syndrome X	0.000808	0.392	CrCbGaD
Gliclazide—Neuropathy—Metformin—metabolic syndrome X	0.000807	0.0244	CcSEcCtD
Gliclazide—VEGFA—adipose tissue—metabolic syndrome X	0.000736	0.102	CbGeAlD
Gliclazide—Injury—Metformin—metabolic syndrome X	0.000679	0.0205	CcSEcCtD
Gliclazide—Renal impairment—Metformin—metabolic syndrome X	0.000656	0.0198	CcSEcCtD
Gliclazide—Hypoglycaemia—Metformin—metabolic syndrome X	0.00064	0.0193	CcSEcCtD
Gliclazide—Pain in extremity—Metformin—metabolic syndrome X	0.000624	0.0189	CcSEcCtD
Gliclazide—KCNJ11—cardiovascular system—metabolic syndrome X	0.000597	0.083	CbGeAlD
Gliclazide—ABCC8—cardiovascular system—metabolic syndrome X	0.00055	0.0764	CbGeAlD
Gliclazide—Abdominal distension—Metformin—metabolic syndrome X	0.000543	0.0164	CcSEcCtD
Gliclazide—ABCC8—kidney—metabolic syndrome X	0.000538	0.0748	CbGeAlD
Gliclazide—Angina pectoris—Metformin—metabolic syndrome X	0.000526	0.0159	CcSEcCtD
Gliclazide—Abdominal discomfort—Metformin—metabolic syndrome X	0.000517	0.0156	CcSEcCtD
Gliclazide—VEGFA—liver—metabolic syndrome X	0.000516	0.0717	CbGeAlD
Gliclazide—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.000501	0.0152	CcSEcCtD
Gliclazide—Drowsiness—Metformin—metabolic syndrome X	0.000481	0.0145	CcSEcCtD
Gliclazide—Neuropathy peripheral—Metformin—metabolic syndrome X	0.000472	0.0143	CcSEcCtD
Gliclazide—Hepatobiliary disease—Metformin—metabolic syndrome X	0.000455	0.0138	CcSEcCtD
Gliclazide—Bradycardia—Metformin—metabolic syndrome X	0.00044	0.0133	CcSEcCtD
Gliclazide—Rhinitis—Metformin—metabolic syndrome X	0.000433	0.0131	CcSEcCtD
Gliclazide—Hepatitis—Metformin—metabolic syndrome X	0.000432	0.0131	CcSEcCtD
Gliclazide—Hypoaesthesia—Metformin—metabolic syndrome X	0.00043	0.013	CcSEcCtD
Gliclazide—Oedema peripheral—Metformin—metabolic syndrome X	0.000425	0.0129	CcSEcCtD
Gliclazide—Eye disorder—Metformin—metabolic syndrome X	0.000404	0.0122	CcSEcCtD
Gliclazide—Flushing—Metformin—metabolic syndrome X	0.000401	0.0121	CcSEcCtD
Gliclazide—Chills—Metformin—metabolic syndrome X	0.000387	0.0117	CcSEcCtD
Gliclazide—Malnutrition—Metformin—metabolic syndrome X	0.000376	0.0114	CcSEcCtD
Gliclazide—Erythema—Metformin—metabolic syndrome X	0.000376	0.0114	CcSEcCtD
Gliclazide—Flatulence—Metformin—metabolic syndrome X	0.00037	0.0112	CcSEcCtD
Gliclazide—Tremor—Metformin—metabolic syndrome X	0.000352	0.0106	CcSEcCtD
Gliclazide—Ill-defined disorder—Metformin—metabolic syndrome X	0.000349	0.0105	CcSEcCtD
Gliclazide—Malaise—Metformin—metabolic syndrome X	0.000339	0.0102	CcSEcCtD
Gliclazide—Palpitations—Metformin—metabolic syndrome X	0.000332	0.01	CcSEcCtD
Gliclazide—Loss of consciousness—Metformin—metabolic syndrome X	0.00033	0.00999	CcSEcCtD
Gliclazide—Hypertension—Metformin—metabolic syndrome X	0.000325	0.00981	CcSEcCtD
Gliclazide—Chest pain—Metformin—metabolic syndrome X	0.00032	0.00967	CcSEcCtD
Gliclazide—Myalgia—Metformin—metabolic syndrome X	0.00032	0.00967	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.000318	0.00961	CcSEcCtD
Gliclazide—Discomfort—Metformin—metabolic syndrome X	0.000316	0.00956	CcSEcCtD
Gliclazide—Infection—Metformin—metabolic syndrome X	0.000305	0.00921	CcSEcCtD
Gliclazide—Nervous system disorder—Metformin—metabolic syndrome X	0.000301	0.0091	CcSEcCtD
Gliclazide—Thrombocytopenia—Metformin—metabolic syndrome X	0.0003	0.00908	CcSEcCtD
Gliclazide—Skin disorder—Metformin—metabolic syndrome X	0.000298	0.00901	CcSEcCtD
Gliclazide—Hyperhidrosis—Metformin—metabolic syndrome X	0.000297	0.00897	CcSEcCtD
Gliclazide—Hypotension—Metformin—metabolic syndrome X	0.000287	0.00867	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.00028	0.00845	CcSEcCtD
Gliclazide—Paraesthesia—Metformin—metabolic syndrome X	0.000275	0.00833	CcSEcCtD
Gliclazide—Dyspnoea—Metformin—metabolic syndrome X	0.000274	0.00827	CcSEcCtD
Gliclazide—Somnolence—Metformin—metabolic syndrome X	0.000273	0.00824	CcSEcCtD
Gliclazide—Dyspepsia—Metformin—metabolic syndrome X	0.00027	0.00816	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000265	0.00801	CcSEcCtD
Gliclazide—Fatigue—Metformin—metabolic syndrome X	0.000265	0.008	CcSEcCtD
Gliclazide—Constipation—Metformin—metabolic syndrome X	0.000262	0.00793	CcSEcCtD
Gliclazide—Feeling abnormal—Metformin—metabolic syndrome X	0.000253	0.00764	CcSEcCtD
Gliclazide—Gastrointestinal pain—Metformin—metabolic syndrome X	0.000251	0.00758	CcSEcCtD
Gliclazide—CYP2C9—cardiovascular system—metabolic syndrome X	0.000246	0.0342	CbGeAlD
Gliclazide—Urticaria—Metformin—metabolic syndrome X	0.000244	0.00737	CcSEcCtD
Gliclazide—ALB—liver—metabolic syndrome X	0.000243	0.0338	CbGeAlD
Gliclazide—Abdominal pain—Metformin—metabolic syndrome X	0.000243	0.00733	CcSEcCtD
Gliclazide—Asthenia—Metformin—metabolic syndrome X	0.00022	0.00665	CcSEcCtD
Gliclazide—Pruritus—Metformin—metabolic syndrome X	0.000217	0.00656	CcSEcCtD
Gliclazide—Diarrhoea—Metformin—metabolic syndrome X	0.00021	0.00635	CcSEcCtD
Gliclazide—Dizziness—Metformin—metabolic syndrome X	0.000203	0.00613	CcSEcCtD
Gliclazide—CYP2C19—liver—metabolic syndrome X	0.000196	0.0273	CbGeAlD
Gliclazide—Vomiting—Metformin—metabolic syndrome X	0.000195	0.0059	CcSEcCtD
Gliclazide—Rash—Metformin—metabolic syndrome X	0.000193	0.00585	CcSEcCtD
Gliclazide—Dermatitis—Metformin—metabolic syndrome X	0.000193	0.00584	CcSEcCtD
Gliclazide—Headache—Metformin—metabolic syndrome X	0.000192	0.00581	CcSEcCtD
Gliclazide—Nausea—Metformin—metabolic syndrome X	0.000182	0.00551	CcSEcCtD
Gliclazide—CYP2C9—liver—metabolic syndrome X	0.000152	0.0211	CbGeAlD
Gliclazide—Glyburide—ALB—metabolic syndrome X	0.000148	0.072	CrCbGaD
Gliclazide—ALB—Transmembrane transport of small molecules—GCK—metabolic syndrome X	2.53e-05	0.000402	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—HTR2C—metabolic syndrome X	2.52e-05	0.0004	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—SCARB1—metabolic syndrome X	2.46e-05	0.000391	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—TRIB3—metabolic syndrome X	2.44e-05	0.000388	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—CETP—metabolic syndrome X	2.44e-05	0.000388	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CYBA—metabolic syndrome X	2.44e-05	0.000388	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—IGF1—metabolic syndrome X	2.4e-05	0.000381	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—metabolic syndrome X	2.39e-05	0.00038	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—GHRL—metabolic syndrome X	2.39e-05	0.00038	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—SREBF1—metabolic syndrome X	2.39e-05	0.000379	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—APOC3—metabolic syndrome X	2.37e-05	0.000377	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—APOB—metabolic syndrome X	2.35e-05	0.000373	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—FMO3—metabolic syndrome X	2.33e-05	0.000371	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	2.32e-05	0.000369	CbGpPWpGaD
Gliclazide—ALB—Metabolism—EPHX2—metabolic syndrome X	2.32e-05	0.000368	CbGpPWpGaD
Gliclazide—ALB—Metabolism—MLXIPL—metabolic syndrome X	2.32e-05	0.000368	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—CETP—metabolic syndrome X	2.31e-05	0.000366	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PLA2G4A—metabolic syndrome X	2.29e-05	0.000363	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—APOB—metabolic syndrome X	2.28e-05	0.000362	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—SERPINE1—metabolic syndrome X	2.28e-05	0.000362	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—IL6—metabolic syndrome X	2.26e-05	0.00036	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CNR1—metabolic syndrome X	2.26e-05	0.000359	CbGpPWpGaD
Gliclazide—VEGFA—Axon guidance—IL6—metabolic syndrome X	2.26e-05	0.000359	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—LPL—metabolic syndrome X	2.24e-05	0.000357	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—PLA2G4A—metabolic syndrome X	2.22e-05	0.000352	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—metabolic syndrome X	2.21e-05	0.000351	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—metabolic syndrome X	2.18e-05	0.000346	CbGpPWpGaD
Gliclazide—ALB—Metabolism—G6PC2—metabolic syndrome X	2.18e-05	0.000346	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—LPL—metabolic syndrome X	2.18e-05	0.000346	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—metabolic syndrome X	2.17e-05	0.000344	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—SREBF1—metabolic syndrome X	2.14e-05	0.000341	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—TGFB1—metabolic syndrome X	2.14e-05	0.00034	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—CD36—metabolic syndrome X	2.13e-05	0.000339	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—FMO3—metabolic syndrome X	2.13e-05	0.000338	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—CETP—metabolic syndrome X	2.1e-05	0.000334	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—TGFB1—metabolic syndrome X	2.1e-05	0.000334	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	2.08e-05	0.000331	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—EPHX2—metabolic syndrome X	2.08e-05	0.00033	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—MLXIPL—metabolic syndrome X	2.08e-05	0.00033	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	2.07e-05	0.000329	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—CD36—metabolic syndrome X	2.07e-05	0.000329	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—metabolic syndrome X	2.01e-05	0.00032	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	2e-05	0.000319	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—TNF—metabolic syndrome X	2e-05	0.000318	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PPARA—metabolic syndrome X	1.98e-05	0.000315	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	1.97e-05	0.000313	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—G6PC2—metabolic syndrome X	1.95e-05	0.000311	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—SREBF1—metabolic syndrome X	1.95e-05	0.000311	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—IGF2—metabolic syndrome X	1.92e-05	0.000306	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—PPARA—metabolic syndrome X	1.92e-05	0.000305	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—AGT—metabolic syndrome X	1.92e-05	0.000305	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	1.9e-05	0.000302	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—EPHX2—metabolic syndrome X	1.9e-05	0.000301	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—MLXIPL—metabolic syndrome X	1.9e-05	0.000301	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—APOE—metabolic syndrome X	1.88e-05	0.000299	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—APOB—metabolic syndrome X	1.87e-05	0.000297	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—AGT—metabolic syndrome X	1.86e-05	0.000296	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—APOA1—metabolic syndrome X	1.86e-05	0.000295	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	1.86e-05	0.000295	CbGpPWpGaD
Gliclazide—ALB—Metabolism—FABP4—metabolic syndrome X	1.85e-05	0.000294	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IGF2—metabolic syndrome X	1.85e-05	0.000294	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—APOE—metabolic syndrome X	1.82e-05	0.00029	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—PLA2G4A—metabolic syndrome X	1.82e-05	0.000289	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—APOA1—metabolic syndrome X	1.8e-05	0.000286	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	1.8e-05	0.000286	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—APOB—metabolic syndrome X	1.79e-05	0.000285	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—G6PC2—metabolic syndrome X	1.78e-05	0.000283	CbGpPWpGaD
Gliclazide—ALB—Metabolism—HSD11B1—metabolic syndrome X	1.75e-05	0.000279	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CCL5—metabolic syndrome X	1.75e-05	0.000279	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.75e-05	0.000278	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—LPL—metabolic syndrome X	1.71e-05	0.000272	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	1.7e-05	0.00027	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—CD36—metabolic syndrome X	1.7e-05	0.000269	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	1.69e-05	0.000269	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—FABP4—metabolic syndrome X	1.66e-05	0.000264	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	1.65e-05	0.000263	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	1.64e-05	0.000261	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PPARG—metabolic syndrome X	1.64e-05	0.00026	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	1.62e-05	0.000258	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—APOB—metabolic syndrome X	1.62e-05	0.000257	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—IL6—metabolic syndrome X	1.61e-05	0.000256	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—INS—metabolic syndrome X	1.61e-05	0.000255	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—PPARG—metabolic syndrome X	1.59e-05	0.000252	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—HSD11B1—metabolic syndrome X	1.58e-05	0.00025	CbGpPWpGaD
Gliclazide—ALB—Metabolism—G6PD—metabolic syndrome X	1.56e-05	0.000249	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—INS—metabolic syndrome X	1.56e-05	0.000248	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	1.54e-05	0.000245	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	1.53e-05	0.000243	CbGpPWpGaD
Gliclazide—ALB—Metabolism—HDAC3—metabolic syndrome X	1.53e-05	0.000243	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—FABP4—metabolic syndrome X	1.52e-05	0.000241	CbGpPWpGaD
Gliclazide—ALB—Metabolism—LPA—metabolic syndrome X	1.49e-05	0.000237	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GCKR—metabolic syndrome X	1.49e-05	0.000237	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—AKT1—metabolic syndrome X	1.49e-05	0.000236	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	1.49e-05	0.000236	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—APOA1—metabolic syndrome X	1.48e-05	0.000235	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—ALB—metabolic syndrome X	1.47e-05	0.000234	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—AGT—metabolic syndrome X	1.47e-05	0.000233	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—AKT1—metabolic syndrome X	1.46e-05	0.000232	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	1.46e-05	0.000232	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PLA2G6—metabolic syndrome X	1.45e-05	0.00023	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—TGFB1—metabolic syndrome X	1.44e-05	0.000228	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—LEP—metabolic syndrome X	1.44e-05	0.000228	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—APOE—metabolic syndrome X	1.44e-05	0.000228	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—HSD11B1—metabolic syndrome X	1.44e-05	0.000228	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	1.43e-05	0.000228	CbGpPWpGaD
Gliclazide—ALB—Metabolism—APOA5—metabolic syndrome X	1.43e-05	0.000227	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—ALB—metabolic syndrome X	1.43e-05	0.000227	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—APOA1—metabolic syndrome X	1.42e-05	0.000226	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—NOS3—metabolic syndrome X	1.41e-05	0.000224	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—G6PD—metabolic syndrome X	1.4e-05	0.000223	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	1.39e-05	0.000221	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	1.39e-05	0.000221	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	1.39e-05	0.00022	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—HDAC3—metabolic syndrome X	1.37e-05	0.000218	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—NOS3—metabolic syndrome X	1.37e-05	0.000217	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	1.36e-05	0.000217	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	1.36e-05	0.000216	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	1.35e-05	0.000215	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	1.35e-05	0.000214	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GCKR—metabolic syndrome X	1.34e-05	0.000213	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—LPA—metabolic syndrome X	1.34e-05	0.000213	CbGpPWpGaD
Gliclazide—ALB—Metabolism—TRIB3—metabolic syndrome X	1.33e-05	0.000211	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	1.33e-05	0.000211	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PLA2G6—metabolic syndrome X	1.3e-05	0.000206	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PTGS2—metabolic syndrome X	1.29e-05	0.000205	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	1.29e-05	0.000205	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—APOA5—metabolic syndrome X	1.28e-05	0.000204	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IRS1—metabolic syndrome X	1.28e-05	0.000204	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—G6PD—metabolic syndrome X	1.28e-05	0.000203	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	1.28e-05	0.000203	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	1.26e-05	0.000201	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—HDAC3—metabolic syndrome X	1.25e-05	0.000199	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—PTGS2—metabolic syndrome X	1.25e-05	0.000199	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	1.25e-05	0.000198	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—IGF1—metabolic syndrome X	1.24e-05	0.000196	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—INS—metabolic syndrome X	1.23e-05	0.000195	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	1.22e-05	0.000194	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—LPA—metabolic syndrome X	1.22e-05	0.000194	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GCKR—metabolic syndrome X	1.22e-05	0.000194	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	1.21e-05	0.000192	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CCL2—metabolic syndrome X	1.21e-05	0.000192	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—TRIB3—metabolic syndrome X	1.19e-05	0.00019	CbGpPWpGaD
Gliclazide—ALB—Metabolism—NAMPT—metabolic syndrome X	1.19e-05	0.00019	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IGF1—metabolic syndrome X	1.19e-05	0.000189	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	1.19e-05	0.000188	CbGpPWpGaD
Gliclazide—ALB—Metabolism—LIPC—metabolic syndrome X	1.19e-05	0.000188	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GCK—metabolic syndrome X	1.19e-05	0.000188	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PLA2G6—metabolic syndrome X	1.18e-05	0.000188	CbGpPWpGaD
Gliclazide—ALB—Metabolism—APOC3—metabolic syndrome X	1.18e-05	0.000187	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	1.17e-05	0.000187	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—SERPINE1—metabolic syndrome X	1.17e-05	0.000187	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—APOA5—metabolic syndrome X	1.17e-05	0.000186	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CETP—metabolic syndrome X	1.14e-05	0.000182	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	1.14e-05	0.000181	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—SERPINE1—metabolic syndrome X	1.13e-05	0.000179	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—NOS3—metabolic syndrome X	1.12e-05	0.000178	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	1.11e-05	0.000177	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	1.1e-05	0.000175	CbGpPWpGaD
Gliclazide—ALB—Metabolism—SCARB1—metabolic syndrome X	1.1e-05	0.000174	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—TRIB3—metabolic syndrome X	1.09e-05	0.000173	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NOS3—metabolic syndrome X	1.08e-05	0.000171	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—NAMPT—metabolic syndrome X	1.07e-05	0.00017	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	1.06e-05	0.000169	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—LIPC—metabolic syndrome X	1.06e-05	0.000169	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GCK—metabolic syndrome X	1.06e-05	0.000169	CbGpPWpGaD
Gliclazide—ALB—Metabolism—SREBF1—metabolic syndrome X	1.06e-05	0.000169	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—APOC3—metabolic syndrome X	1.06e-05	0.000168	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GOT2—metabolic syndrome X	1.03e-05	0.000164	CbGpPWpGaD
Gliclazide—ALB—Metabolism—HMGCR—metabolic syndrome X	1.03e-05	0.000164	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CETP—metabolic syndrome X	1.03e-05	0.000163	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—AKT1—metabolic syndrome X	9.99e-06	0.000159	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—SCARB1—metabolic syndrome X	9.83e-06	0.000156	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—NAMPT—metabolic syndrome X	9.76e-06	0.000155	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	9.71e-06	0.000154	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—LIPC—metabolic syndrome X	9.7e-06	0.000154	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GCK—metabolic syndrome X	9.7e-06	0.000154	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—APOC3—metabolic syndrome X	9.64e-06	0.000153	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	9.57e-06	0.000152	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—SREBF1—metabolic syndrome X	9.54e-06	0.000152	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CETP—metabolic syndrome X	9.36e-06	0.000149	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	9.33e-06	0.000148	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—HMGCR—metabolic syndrome X	9.28e-06	0.000148	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GOT2—metabolic syndrome X	9.28e-06	0.000148	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ABCA1—metabolic syndrome X	9.22e-06	0.000147	CbGpPWpGaD
Gliclazide—ALB—Metabolism—SLC2A4—metabolic syndrome X	9.22e-06	0.000147	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—SCARB1—metabolic syndrome X	8.96e-06	0.000142	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GGT1—metabolic syndrome X	8.93e-06	0.000142	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GOT1—metabolic syndrome X	8.93e-06	0.000142	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	8.73e-06	0.000139	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—SREBF1—metabolic syndrome X	8.7e-06	0.000138	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—HMGCR—metabolic syndrome X	8.47e-06	0.000135	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GOT2—metabolic syndrome X	8.47e-06	0.000135	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	8.37e-06	0.000133	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ABCA1—metabolic syndrome X	8.28e-06	0.000132	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—SLC2A4—metabolic syndrome X	8.28e-06	0.000132	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GGT1—metabolic syndrome X	8.01e-06	0.000127	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GOT1—metabolic syndrome X	8.01e-06	0.000127	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	7.64e-06	0.000121	CbGpPWpGaD
Gliclazide—ALB—Metabolism—APOB—metabolic syndrome X	7.58e-06	0.00012	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ABCA1—metabolic syndrome X	7.55e-06	0.00012	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—SLC2A4—metabolic syndrome X	7.55e-06	0.00012	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—TGFB1—metabolic syndrome X	7.41e-06	0.000118	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PLA2G4A—metabolic syndrome X	7.37e-06	0.000117	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GGT1—metabolic syndrome X	7.31e-06	0.000116	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GOT1—metabolic syndrome X	7.31e-06	0.000116	CbGpPWpGaD
Gliclazide—ALB—Metabolism—LPL—metabolic syndrome X	7.23e-06	0.000115	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TGFB1—metabolic syndrome X	7.12e-06	0.000113	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CD36—metabolic syndrome X	6.87e-06	0.000109	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—APOB—metabolic syndrome X	6.8e-06	0.000108	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PLA2G4A—metabolic syndrome X	6.62e-06	0.000105	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—LPL—metabolic syndrome X	6.49e-06	0.000103	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—AKT1—metabolic syndrome X	6.48e-06	0.000103	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PPARA—metabolic syndrome X	6.39e-06	0.000102	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—AKT1—metabolic syndrome X	6.28e-06	9.98e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—APOB—metabolic syndrome X	6.2e-06	9.86e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—AGT—metabolic syndrome X	6.19e-06	9.84e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CD36—metabolic syndrome X	6.17e-06	9.81e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—APOE—metabolic syndrome X	6.06e-06	9.64e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PLA2G4A—metabolic syndrome X	6.03e-06	9.59e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—APOA1—metabolic syndrome X	5.99e-06	9.53e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—LPL—metabolic syndrome X	5.92e-06	9.41e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PPARA—metabolic syndrome X	5.74e-06	9.12e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CD36—metabolic syndrome X	5.63e-06	8.94e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—AGT—metabolic syndrome X	5.56e-06	8.83e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—APOE—metabolic syndrome X	5.44e-06	8.65e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—APOA1—metabolic syndrome X	5.38e-06	8.55e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IL6—metabolic syndrome X	5.36e-06	8.52e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PPARG—metabolic syndrome X	5.28e-06	8.39e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PPARA—metabolic syndrome X	5.23e-06	8.31e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—INS—metabolic syndrome X	5.18e-06	8.23e-05	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—AKT1—metabolic syndrome X	5.15e-06	8.19e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—AGT—metabolic syndrome X	5.07e-06	8.05e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—APOE—metabolic syndrome X	4.96e-06	7.89e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—AKT1—metabolic syndrome X	4.95e-06	7.86e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—APOA1—metabolic syndrome X	4.91e-06	7.8e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PPARG—metabolic syndrome X	4.74e-06	7.54e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—INS—metabolic syndrome X	4.65e-06	7.39e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—NOS3—metabolic syndrome X	4.54e-06	7.22e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PPARG—metabolic syndrome X	4.32e-06	6.87e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ALB—metabolic syndrome X	4.26e-06	6.78e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—INS—metabolic syndrome X	4.24e-06	6.74e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PTGS2—metabolic syndrome X	4.15e-06	6.6e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—NOS3—metabolic syndrome X	4.08e-06	6.48e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ALB—metabolic syndrome X	3.89e-06	6.18e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PTGS2—metabolic syndrome X	3.73e-06	5.93e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—NOS3—metabolic syndrome X	3.72e-06	5.91e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PTGS2—metabolic syndrome X	3.4e-06	5.4e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—AKT1—metabolic syndrome X	2.09e-06	3.32e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—AKT1—metabolic syndrome X	1.87e-06	2.98e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—AKT1—metabolic syndrome X	1.71e-06	2.72e-05	CbGpPWpGaD
